Evidence map›Paper›PMID 39470788›Full record

Trial reportEuropean child & adolescent psychiatry2025

Early remission of deliberate self-harm predicts emotion regulation capacity in adulthood: 12.4 years follow-up of a randomized controlled trial of adolescents with repeated self-harm and borderline features.

Iselin Solerød Dibaj, Anita Johanna Tørmoen, Ole Klungsøyr, Katharina Teresa Enehaug Morken, Egil Haga, Kine Johansen Dymbe, Lars Mehlum

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European child & adolescent psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00675129 phase2completednot on this map

A Randomized Controlled Trial for Repetitive Deliberate Self-harm and Suicidal Behaviours Among Norwegian Adolescents: a Comparison Between Dialectical Behaviour Therapy Adapted for Adolescents (DBT-A) and Enhanced Usual Care (EUC)

TypeinterventionalSponsorOslo University HospitalRan2008 to 2013Enrolled77ConditionsIntentional Self HarmArmsDialectical behavioral therapy for adolescents (DBT-A), Treatment as usual
NCT07450105 naenrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Intensive Dialectical Behavior Therapy for Self-Harm and Suicidal Behavior in Youth: A Pilot Study

TypeinterventionalSponsorHaukeland University HospitalRan2026 to 2027Enrolled12ConditionsSelf-Harm, Deliberate, Suicidal Behavior, Borderline Personality Disorder (BPD)ArmsIntensive Dialectical Behavior Therapy
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Iselin Solerød Dibaj, Sognsvannsveien 21, 0372, Oslo, Norway. iselin.dibaj@medisin.uio.no.
Anita Johanna Tørmoen, Sognsvannsveien 21, 0372, Oslo, Norway.
Ole Klungsøyr, Sognsvannsveien 21, 0372, Oslo, Norway.
Katharina Teresa Enehaug Morken, Årstadveien 17, 5009, Bergen, Norway.
Egil Haga, Sognsvannsveien 21, 0372, Oslo, Norway.
Kine Johansen Dymbe, Sognsvannsveien 21, 0372, Oslo, Norway.
Lars Mehlum, Sognsvannsveien 21, 0372, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emotion regulation capacity, critical for adult functioning and mental health, develops strongly during adolescence in healthy individuals. Deficits in emotion regulation is often referred to as emotion dysregulation [ED] and is associated with various mental health problems, including repeated deliberate self-harm [DSH] which peaks in adolescence. Dialectical Behaviour Therapy for adolescents [DBT-A] systematically targets ED through strategies such as changing coping behaviours and has previously been shown to effectively induce DSH remission in adolescents. However, whether such remission is associated with improved emotion regulation capacity in adulthood, and whether this effect is mediated by changes in use of coping strategies has not been previously studied. Prospective long-term follow-up study of an RCT comparing DBT-A with enhanced usual care [EUC] for adolescents presenting to community child and adolescent psychiatric outpatient clinics with borderline personality features and repeated self-harm. Assessments included both structured interviews and self-report at baseline and 1.6, 3.1 and 12.4 years follow-up. In the final follow-up, adult ED was measured and data were collected for 61 (80%) of the original 77 participants. DSH remission was assessed at 1.6 years follow-up, and use of coping strategies at 3.1 and 12.4 years follow-ups. A mediation analysis was conducted within a causal inference framework. Both treatment groups increased their use of functional coping skills from adolescence to adulthood, while only DBT-A was associated with decreases in dysfunctional coping. There was a direct effect of DSH remission 1 year after treatment on adult ED, particularly for participants who did not receive DBT-A. There was a negative association between reductions in dysfunctional coping and adult ED, however this did not mediate the effect of DSH remission. This is the first study to report that early DSH remission in adolescence predicted lower ED in adulthood. These results highlight the importance of early DSH remission and provides new insight into the long-term relationship between DSH and ED. Clinical trial registration information: "Treatment for Adolescents with Deliberate Self-harm"; http://ClinicalTrials.gov/;NCT00675129.

Indexed as

Adaptation, PsychologicalBorderline Personality DisorderDialectical Behavior TherapyEmotional RegulationSelf-Injurious BehaviorAdolescentAdultFemaleFollow-Up StudiesHumansMaleRemission InductionYoung AdultAdolescenceCoping strategiesDBTEmotion regulationSelf-harm

Identifiers

PMID39470788
PMCPMC12198333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.